Bausch + Lomb (NYSE:BLCO) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Bausch + Lomb Corporation Common Shares (BLCO)
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
BLCO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLCO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLCO alerts
High impacting Bausch + Lomb Corporation Common Shares news events
Weekly update
A roundup of the hottest topics
BLCO
News
- Bausch + Lomb CEO Brent Saunders sits down with Jim Cramer [CNBC]CNBC
- Trump says DEI, civil rights policies hurt White people. Do they? [USA TODAY]USA TODAY
- Bausch + Lomb (NYSE:BLCO) was downgraded by analysts at Evercore ISI from a "strong-buy" rating to a "hold" rating.MarketBeat
- Bausch + Lomb (NYSE:BLCO) was given a new $18.00 price target on by analysts at Evercore ISI.MarketBeat
- Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S. [Yahoo! Finance]Yahoo! Finance
BLCO
Earnings
- 10/29/25 - Beat
BLCO
Sec Filings
- 1/9/26 - Form 3
- 1/9/26 - Form 3
- 1/2/26 - Form 8-K
- BLCO's page on the SEC website